Literature DB >> 3262057

The role of beta-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IX.

D J Rees1, I M Jones, P A Handford, S J Walter, M P Esnouf, K J Smith, G G Brownlee.   

Abstract

beta-Hydroxyaspartic acid is a post-translationally modified amino acid found in a number of plasma proteins in a domain homologous to epidermal growth factor. Its presence can be correlated with a high affinity Ca2+ binding site, with a dissociation constant of 10-100 microM. We describe a system for the expression of human coagulation factor IX in dog kidney cells in tissue culture, in which the post-translational modifications and the biochemical activity are indistinguishable from factor IX synthesized in vivo. This system has been used to express eight different point mutations of human factor IX in the first epidermal growth factor domain in order to study the role of beta-hydroxyaspartate at residue 64, and the adjacent carboxylate residues at positions 47, 49 and 78. We conclude that this domain is essential for factor IX function and suggest that Ca2+ binds to carboxylate ions in this domain and stabilizes a conformation necessary for the interaction of factor IXa with factor X, factor VIII and phospholipid in the next step of the clotting cascade.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262057      PMCID: PMC454485          DOI: 10.1002/j.1460-2075.1988.tb03045.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

1.  Profile analysis: detection of distantly related proteins.

Authors:  M Gribskov; A D McLachlan; D Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

2.  Factor IXAlabama: a point mutation in a clotting protein results in hemophilia B.

Authors:  L M Davis; R A McGraw; J L Ware; H R Roberts; D W Stafford
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

3.  Proteolytic formation and properties of gamma-carboxyglutamic acid-domainless protein C.

Authors:  N L Esmon; L E DeBault; C T Esmon
Journal:  J Biol Chem       Date:  1983-05-10       Impact factor: 5.157

Review 4.  Zymogens and cofactors of blood coagulation.

Authors:  Y Nemerson; B Furie
Journal:  CRC Crit Rev Biochem       Date:  1980

5.  The propeptide region of clotting factor IX is a signal for a vitamin K dependent carboxylase: evidence from protein engineering of amino acid -4.

Authors:  P Galeffi; G G Brownlee
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

6.  Recognition site directing vitamin K-dependent gamma-carboxylation resides on the propeptide of factor IX.

Authors:  M J Jorgensen; A B Cantor; B C Furie; C L Brown; C B Shoemaker; B Furie
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

7.  Comparison of lipid binding and kinetic properties of normal, variant, and gamma-carboxyglutamic acid modified human factor IX and factor IXa.

Authors:  M E Jones; M J Griffith; D M Monroe; H R Roberts; B R Lentz
Journal:  Biochemistry       Date:  1985-12-31       Impact factor: 3.162

8.  Calcium binding of bovine protein S. Effect of thrombin cleavage and removal of the gamma-carboxyglutamic acid-containing region.

Authors:  T Sugo; B Dahlbäck; A Holmgren; J Stenflo
Journal:  J Biol Chem       Date:  1986-04-15       Impact factor: 5.157

9.  Isolation and sequence of the cDNA for human protein S, a regulator of blood coagulation.

Authors:  A Lundwall; W Dackowski; E Cohen; M Shaffer; A Mahr; B Dahlbäck; J Stenflo; R Wydro
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

10.  Mouse H-2k-restricted cytotoxic T cells recognize antigenic determinants in both the HA1 and HA2 subunits of the influenza A/PR/8/34 hemagglutinin.

Authors:  K G Gould; H Scotney; A R Townsend; J Bastin; G G Brownlee
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

View more
  36 in total

Review 1.  C1q receptors.

Authors:  P Eggleton; A J Tenner; K B Reid
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

2.  Regions 301-303 and 333-339 in the catalytic domain of blood coagulation factor IX are factor VIII-interactive sites involved in stimulation of enzyme activity.

Authors:  J A Kolkman; P J Lenting; K Mertens
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

3.  Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B.

Authors:  J Y Chang; D M Monroe; D W Stafford; K M Brinkhous; H R Roberts
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

4.  Fibrillin-containing microfibrils are key signal relay stations for cell function.

Authors:  Karina A Zeyer; Dieter P Reinhardt
Journal:  J Cell Commun Signal       Date:  2015-10-08       Impact factor: 5.782

5.  An epidermal growth factor-like repeat of Del1 protein increases the efficiency of gene transfer in vitro.

Authors:  Hisataka Kitano; Chiaki Hidai; Masatoshi Kawana; Shinichiro Kokubun
Journal:  Mol Biotechnol       Date:  2008-03-06       Impact factor: 2.695

Review 6.  The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system.

Authors:  M Hessing
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

7.  The three-dimensional structure of the first EGF-like module of human factor IX: comparison with EGF and TGF-alpha.

Authors:  M Baron; D G Norman; T S Harvey; P A Handford; M Mayhew; A G Tse; G G Brownlee; I D Campbell
Journal:  Protein Sci       Date:  1992-01       Impact factor: 6.725

8.  Replacement of isoleucine-397 by threonine in the clotting proteinase factor IXa (Los Angeles and Long Beach variants) affects macromolecular catalysis but not L-tosylarginine methyl ester hydrolysis. Lack of correlation between the ox brain prothrombin time and the mutation site in the variant proteins.

Authors:  S G Spitzer; B J Warn-Cramer; C K Kasper; S P Bajaj
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

9.  Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domain.

Authors:  S P Bajaj; A K Sabharwal; J Gorka; J J Birktoft
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

10.  Structural analysis of the uEGF gene in the sea urchin strongylocentrotus purpuratus reveals more similarity to vertebrate than to invertebrate genes with EGF-like repeats.

Authors:  M G Delgadillo-Reynoso; D R Rollo; D A Hursh; R A Raff
Journal:  J Mol Evol       Date:  1989-10       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.